BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) —

Sensus Healthcare, Inc. (Nasdaq: SRTS

), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be participating in the H.C. Wainwright Global Investment Conference taking place virtually and in-person at the Fontainebleau Miami Beach May 23-26, 2022.

Sensus management will deliver a corporate presentation on May 25 at 9:30 a.m. Eastern time, and the live and archived presentation will be available on the Company’s website


here


.  In addition, Michael Sardano, president and general counsel, and Javier Rampolla, chief financial officer, will be holding one-on-one meetings with the investment community both virtually and in-person at the conference.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100

^™

, SRT-100+

^™

and SRT-100 Vision

^™

systems. With its portfolio of innovative medical device products, including aesthetic lasers and its needleless TransDermal Infusion System

^™

, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

For more information, visit


www.sensushealthcare.com


.

Contact:




LHA Investor Relations

Kim Sutton Golodetz

212-838-3777



[email protected]

#   #   #